Completed Phase I DIONE-01 study demonstrates clinical activity and long-term safety of roginolisib, a unique allosteric modulator of PI3Kδ Patients with uveal melanoma showed a doubling of overall survival compared to historical controls Site activation […]
#Rosal Top Picks
Recent Posts
- LES AVENTURES DE JACQUES, VIC ET OTTO En route pour
- About Hemlo Mining Corp. Hemlo Mining Corp. (up to now
- -TCL mostrará el futuro con innovaciones visuales
- HOFFMAN ESTATES, In poor health., Dec. 18, 2025
- TRIANGLE, Va., Dec. 18, 2025 /PRNewswire/ — As
